ArticleCurrent oncology (Toronto, Ont.)2025

Multicenter Real-World Study: 432 Patients with Apalutamide in Metastatic Hormone-Sensitive Prostate Cancer.

Juan A Encarnación Navarro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.